McKesson Board of Directors Elects Dominic Caruso as New Independent Director
September 13 2018 - 04:10PM
Business Wire
McKesson Corporation (NYSE:MCK) today announced that its Board
of Directors has elected Dominic Caruso as a new independent
director, effective September 12, 2018. With the election of
Dominic Caruso, McKesson’s Board of Directors increases from eight
to nine members, eight of whom are independent.
“Dominic’s three decades of global financial and operational
experience, leadership, and tenure in the healthcare industry make
him an ideal addition to our Board of Directors,” said John H.
Hammergren, chairman and chief executive officer, McKesson
Corporation. “His demonstrated commitment to rigorous financial
stewardship complements McKesson’s dedication to strong financial
management, disciplined growth and strategic capital
allocation.”
“I'm delighted to be joining a company that I've long admired
and look forward to adding my perspective and contributing to the
company's future development and success,” added Dominic Caruso.
“McKesson’s market leadership and deep customer and partner
relationships position it for long-term growth in the healthcare
industry. I look forward to helping chart the company’s path
forward.”
Dominic Caruso
Dominic Caruso, age 61, retired as executive vice president and
chief financial officer from Johnson & Johnson in August 2018,
having served in the role since 2007. Dominic led the company’s
financial and investor relations activities, as well as the
procurement organization. Dominic joined Johnson & Johnson in
October 1999 as chief financial officer for Centocor, Inc., upon
the completion of the merger of Centocor and Johnson & Johnson.
Prior to joining Centocor, he had varied industry experiences with
KPMG.
Dominic is actively involved in government relations activities
globally, including having served as the co-chair of the U.S.
Chamber of Commerce Global Initiative on Health and the Economy. He
currently serves on the Board of Trustees of The Children’s
Hospital of Philadelphia and the Cystic Fibrosis Foundation.
McKesson’s Board has appointed Dominic to its Audit Committee
and its Finance Committee.
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE 500,
is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and
healthcare information technology. McKesson partners with
pharmaceutical manufacturers, providers, pharmacies, governments
and other organizations in healthcare to help provide the right
medicines, medical products and healthcare services to the right
patients at the right time, safely and cost-effectively. United by
our ICARE shared principles, our employees work every day to
innovate and deliver opportunities that make our customers and
partners more successful — all for the better health of patients.
McKesson has been named the “Most Admired Company” in the
healthcare wholesaler category by FORTUNE, a “Best Place to Work”
by the Human Rights Campaign Foundation, and a
top military-friendly company by Military Friendly. For
more information, visit www.mckesson.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180913006039/en/
McKesson CorporationCraig Mercer, 415-983-8391 (Investors and
Financial Media)Craig.Mercer@McKesson.comorApril Marks,
415-732-1384 (General and Business
Media)April.Marks@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Feb 2024 to Mar 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Mar 2023 to Mar 2024